{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T23:24:54Z","timestamp":1773444294978,"version":"3.50.1"},"reference-count":15,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,11,3]]},"abstract":"<jats:p>We report two patients with chronic myelogenous leukaemia (CML) in remission phase who developed panuveitis simulating Beh\u00e7et\u2019s disease. A 26-year-old man presented with bilateral panuveitis (hypopyon in the right eye, bilateral anterior segment inflammation, vitritis and retinitis). He was on imatinib for CML which was in remission. He gave a history of recurrent oral ulcers. The panuveitis responded to oral and topical steroids but recurred after the steroids were stopped. His ocular condition again stabilised on restarting oral steroids and azathioprine. The second patient, a 28-year-old man, presented with bilateral anterior segment inflammation, vitritis, exudative retinal detachment and hypopyon in the right eye. He was also on imatinib with the CML being in remission. The uveitis and exudative retinal detachment improved on systemic and topical steroids. The vision of this patient did not improve as optic atrophy ensued. The panuveitis seen in our patients with CML responded favourably to oral steroids\/immunosuppressant therapy.<\/jats:p>","DOI":"10.1136\/bcr-2017-222238","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T10:35:31Z","timestamp":1511433331000},"page":"bcr-2017-222238","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Panuveitis simulating ocular Beh\u00e7et\u2019s in cases of chronic myelogenous leukaemia in remission"],"prefix":"10.1136","volume":"2017","author":[{"given":"Rohan","family":"Chawla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9756-128X","authenticated-orcid":false,"given":"Koushik","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050255"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.2","first-page":"1183","article-title":"Beh\u00e7et\u2019s disease induced by interferon therapy for chronic myelogenous leukemia","volume":"22","author":"Segawa","year":"1995","journal-title":"J Rheumatol"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.3","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000067864"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/1096-8652(200101)66:1<57::AID-AJH1010>3.0.CO;2-3","article-title":"Behcet\u2019s disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature","volume":"66","author":"Vaiopoulos","year":"2001","journal-title":"Am J Hematol"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.5","doi-asserted-by":"crossref","unstructured":"Deng X , Dong Y , Zhang Z . The development of beh\u00e7et\u2019s disease in a patient with chronic myeloid leukemia. Research 2014;1.doi:10.13070\/rs.en.1.823","DOI":"10.13070\/rs.en.1.823"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.6","first-page":"929","article-title":"Treatment of colitis in Beh\u00e7et\u2019s disease with thalidomide","volume":"8","author":"Postema","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.7","first-page":"67","article-title":"[Beh\u00e7et\u2019s disease with an onset prior to the appearance of chronic myeloid leukemia]","volume":"99","author":"Tassies","year":"1992","journal-title":"Med Clin"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1346-8138.1999.tb03510.x","article-title":"Hydroxyurea-related leg ulcers in a patient with chronic myelogenous leukemia: a case report and review of the literature","volume":"26","author":"Kato","year":"1999","journal-title":"J Dermatol"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.9","doi-asserted-by":"publisher","DOI":"10.4103\/0974-620X.149896"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08820538.2015.1045153","article-title":"Periarterial plaques (kyrieleis' arteriolitis) in a case of bilateral acute retinal necrosis","volume":"32","author":"Chawla","year":"2017","journal-title":"Semin Ophthalmol"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.11","first-page":"1078","article-title":"Criteria for diagnosis of beh\u00e7et\u2019s disease. International study group for beh\u00e7et\u2019s disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.11.026"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00859.x"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2559.2004.01954.x","article-title":"Neutrophilic phlebitis is characteristic of intestinal Beh\u00e7et\u2019s disease and simple ulcer syndrome","volume":"45","author":"Hayasaki","year":"2004","journal-title":"Histopathology"},{"key":"2025042713071058000_2017.nov22_1.bcr-2017-222238.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380321"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-222238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T20:07:21Z","timestamp":1745784441000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-222238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":15,"alternative-id":["10.1136\/bcr-2017-222238"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-222238","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,23]]}}}